YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial
Listen to this summary
This study aimed to evaluate the safety and efficiency of the YEARS algorithm for diagnosing suspected pulmonary embolism (PE) in patients with active cancer, compared to the standard approach of computed tomographic pulmonary angiography (CTPA) only. The results indicated that the YEARS algorithm was as safe as CTPA, allowing for a reduction in unnecessary CTPA procedures in 22% of patients. Thus, the YEARS algorithm could serve as a viable alternative for ruling out PE in this patient population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from JAMA
View all →Jul 9, 2026 · JAMA
Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States
Jul 8, 2026 · JAMA
Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer
Jul 6, 2026 · JAMA
Alcohol-Related Liver Disease: A Review
Jul 1, 2026 · JAMA
Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical Trial
Jun 24, 2026 · JAMA
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial
Jun 17, 2026 · JAMA
Prone Positioning in Infants With Acute Bronchiolitis: The PROPOSITIS Randomized Clinical Trial
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Jul 10, 2026 · Lancet (London, England)
Advancing the relevance of clinical trials for older patients
Jul 9, 2026 · Lancet (London, England)
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial
Jul 9, 2026 · Circulation
Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association
Jul 9, 2026 · Lancet (London, England)
Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations
Jul 9, 2026 · Lancet (London, England)
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial
Jul 8, 2026 · The New England journal of medicine
Meningococcal B Vaccine to Prevent <em>Neisseria gonorrhoeae</em> Infection
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
